Literature DB >> 12682619

Hantaviruses: a tale of two hemispheres.

A Khan1, A S Khan.   

Abstract

Infectious febrile nephropathies, initially described as epidemics during military campaigns in Europe and Asia at the turn of the 20(th) century, were eventually all unified under the rubric of hemorrhagic fever with renal syndrome (HFRS) and ascribed to infection from rodent-borne hantaviruses. At the end of the century, hantavirus pulmonary syndrome (HPS) was described throughout the Americas as a consequence of infection with the New World hantaviruses. The epidemiology and clinical manifestations of these diseases are linked to the ecology of their associated rodent hosts. Murine rodents (Old World mice and rats) are associated with the severe forms of HFRS in Asia and the Balkans due to Hantaan, Dobrava, and Seoul viruses. Hantaan virus causes an estimated 50-100,000 infections a year in China alone. Arvicoline rodents (voles) are associated with a mild form of HFRS in Europe called nephropathia epidemica due to Puumala virus. Sigmodontine rodents (New World rats and mice) are associated with approximately 200 HPS cases per year throughout the Americas caused by over a dozen viruses. The viruses are mainly transmitted as small-particle aerosols of rodent excreta, and the subsequent infections share cardiovascular shock as a prominent feature, although HFRS causes predominantly renal disease, while HPS causes a predominantly non-cardiogenic pulmonary edema - hemorrhage involvement varies in the syndromes on the basis of virus subtypes. Efforts are underway to refine prevention strategies, understand the pathogenesis of the shock, and identify therapeutic modalities.

Entities:  

Mesh:

Year:  2003        PMID: 12682619

Source DB:  PubMed          Journal:  Panminerva Med        ISSN: 0031-0808            Impact factor:   5.197


  7 in total

Review 1.  Treatment of hantavirus pulmonary syndrome.

Authors:  Colleen B Jonsson; Jay Hooper; Gregory Mertz
Journal:  Antiviral Res       Date:  2007-11-21       Impact factor: 5.970

Review 2.  Hantaviruses.

Authors:  Mohammed A Mir
Journal:  Clin Lab Med       Date:  2010-03       Impact factor: 1.935

3.  Ribavirin reveals a lethal threshold of allowable mutation frequency for Hantaan virus.

Authors:  Dong-Hoon Chung; Yanjie Sun; William B Parker; Jeffrey B Arterburn; Al Bartolucci; Colleen B Jonsson
Journal:  J Virol       Date:  2007-08-15       Impact factor: 5.103

4.  Potential renal sequelae in survivors of hantavirus cardiopulmonary syndrome.

Authors:  Steven A Pergam; Darren W Schmidt; Robert A Nofchissey; William C Hunt; Antonia H Harford; Diane E Goade
Journal:  Am J Trop Med Hyg       Date:  2009-02       Impact factor: 2.345

5.  Hantavirus infection--hemorrhagic fever with renal syndrome: the first case series reported in Romania and review of the literature.

Authors:  Irinel-Doina Maftei; Liviu Segall; Raluca Panculescu-Gatej; Cornelia Ceianu; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2011-06-16       Impact factor: 2.266

6.  Depletion of Alveolar Macrophages Does Not Prevent Hantavirus Disease Pathogenesis in Golden Syrian Hamsters.

Authors:  Christopher D Hammerbeck; Rebecca L Brocato; Todd M Bell; Christopher W Schellhase; Steven R Mraz; Laurie A Queen; Jay W Hooper
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

Review 7.  Emerging and re-emerging viral infections in Europe.

Authors:  Agostino Pugliese; Tiziana Beltramo; Donato Torre
Journal:  Cell Biochem Funct       Date:  2007 Jan-Feb       Impact factor: 3.685

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.